Jaime Kulisevsky

35.1k total citations · 5 hit papers
321 papers, 13.8k citations indexed

About

Jaime Kulisevsky is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Jaime Kulisevsky has authored 321 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 236 papers in Neurology, 94 papers in Cellular and Molecular Neuroscience and 65 papers in Cognitive Neuroscience. Recurrent topics in Jaime Kulisevsky's work include Parkinson's Disease Mechanisms and Treatments (187 papers), Neurological disorders and treatments (156 papers) and Genetic Neurodegenerative Diseases (61 papers). Jaime Kulisevsky is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (187 papers), Neurological disorders and treatments (156 papers) and Genetic Neurodegenerative Diseases (61 papers). Jaime Kulisevsky collaborates with scholars based in Spain, United States and United Kingdom. Jaime Kulisevsky's co-authors include Javier Pagonabarraga, Alexandre Gironell, Berta Pascual‐Sedano, Dag Aarsland, Carmen García‐Sánchez, Daniel Weintraub, Murat Emre, Saül Martínez‐Horta, Alexander I. Tröster and María Rodríguez‐Oroz and has published in prestigious journals such as New England Journal of Medicine, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Jaime Kulisevsky

308 papers receiving 13.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

2012 1.9k citations Dag Aarsland, Jaime Kulisevsky et al. Movement Disorders profile →
Rivastigmine for Dementia Associated with Parkinson's Disease

2004 793 citations Murat Emre, Dag Aarsland et al. New England Journal of Medicine profile →
MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI

2011 585 citations Dag Aarsland, Jaime Kulisevsky et al. Movement Disorders profile →
Mild cognitive impairment in Parkinson disease

2010 569 citations Dag Aarsland, Jaime Kulisevsky et al. Neurology profile →
Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment

2015 359 citations Javier Pagonabarraga, Jaime Kulisevsky et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jaime Kulisevsky Spain	55	9.4k	3.9k	3.3k	2.8k	1.5k	321	13.8k
Andrew Siderowf United States	60	10.5k 1.1×	2.5k 0.6×	2.8k 0.8×	2.6k 0.9×	1.4k 0.9×	185	14.5k
Murat Emre Türkiye	47	7.1k 0.8×	2.4k 0.6×	3.2k 1.0×	1.9k 0.7×	1.5k 1.0×	164	11.9k
Bruno Dubois France	50	12.0k 1.3×	4.1k 1.0×	3.1k 1.0×	3.4k 1.2×	2.1k 1.4×	106	17.1k
Glenn T. Stebbins United States	72	12.0k 1.3×	5.0k 1.3×	4.0k 1.2×	3.0k 1.1×	1.3k 0.9×	271	18.1k
Paolo Barone Italy	71	12.3k 1.3×	3.4k 0.9×	2.7k 0.8×	4.2k 1.5×	1.5k 1.0×	418	17.6k
Caroline H. Williams‐Gray United Kingdom	45	7.4k 0.8×	2.4k 0.6×	2.0k 0.6×	1.8k 0.7×	1.6k 1.1×	113	10.2k
Alexander I. Tröster United States	51	8.1k 0.9×	3.3k 0.8×	3.1k 0.9×	2.3k 0.8×	1.3k 0.9×	143	11.8k
María Rodríguez‐Oroz Spain	54	10.8k 1.1×	3.1k 0.8×	1.5k 0.5×	5.1k 1.8×	1.8k 1.2×	147	13.8k
Howard I. Hurtig United States	63	9.5k 1.0×	2.5k 0.6×	2.4k 0.7×	3.0k 1.1×	2.1k 1.4×	140	13.9k
Cristina Sampaio United States	57	10.8k 1.2×	2.3k 0.6×	2.4k 0.7×	3.7k 1.3×	1.1k 0.7×	199	15.5k

Countries citing papers authored by Jaime Kulisevsky

Since Specialization

Citations

This map shows the geographic impact of Jaime Kulisevsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime Kulisevsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime Kulisevsky more than expected).

Fields of papers citing papers by Jaime Kulisevsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaime Kulisevsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime Kulisevsky. The network helps show where Jaime Kulisevsky may publish in the future.

Co-authorship network of co-authors of Jaime Kulisevsky

This figure shows the co-authorship network connecting the top 25 collaborators of Jaime Kulisevsky. A scholar is included among the top collaborators of Jaime Kulisevsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaime Kulisevsky. Jaime Kulisevsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pérez‐Pérez, Jesús, et al.. (2025). Update on Genetic Chorea. European Journal of Neurology. 32(10). e70357–e70357.

Daniels, Christine, et al.. (2024). Cognitive disorders in advanced Parkinson’s disease: challenges in the diagnosis of delirium. SHILAP Revista de lepidopterología. 6(1). 14–14. 4 indexed citations

Weis, Luca, Eleonora Fiorenzato, Margherita Canesi, et al.. (2024). Validation of the Italian version of the Parkinson’s Disease- Cognitive Functional Rating Scale. Journal of Neural Transmission. 131(4). 305–314. 3 indexed citations

Pérez‐Pérez, Jesús, Andrea Horta‐Barba, Elena Vacchi, et al.. (2024). Skin Tau Quantification as a Novel Biomarker in Huntington's Disease. Movement Disorders. 39(11). 2067–2074. 4 indexed citations

Szász, József Attila, et al.. (2023). Impact of Infusion Therapies on Quality of Life in Advanced Parkinson’s Disease. Neuropsychiatric Disease and Treatment. Volume 19. 1959–1972. 4 indexed citations

Pérez‐Pérez, Jesús, et al.. (2023). Cerebellar Syndrome Induced by Hypomagnesemia: A Treatable Cause of Ataxia Not to be Missed. Report of Three Cases and a Review of the Literature. Movement Disorders Clinical Practice. 10(6). 1004–1012. 2 indexed citations

Rodríguez‐Santiago, Benjamín, et al.. (2023). Late‐Onset Beta‐Propeller Protein‐Associated Neurodegeneration: A Case Report. Movement Disorders Clinical Practice. 10(8). 1211–1214. 2 indexed citations

Horta‐Barba, Andrea, Saül Martínez‐Horta, Jesús Pérez‐Pérez, et al.. (2023). Structural and metabolic brain correlates of arithmetic word‐problem solving in Huntington's disease. Journal of Neuroscience Research. 101(6). 990–999. 3 indexed citations

Martínez‐Horta, Saül, et al.. (2021). Effects of a Green Oat Herb Extract on Cognitive Performance and Neurophysiological Activity: A Randomized Double-Blind Placebo-Controlled Study. Frontiers in Neuroscience. 15. 748188–748188. 2 indexed citations

10.

Pagonabarraga, Javier, Joaquín Morís, Saül Martínez‐Horta, et al.. (2021). Neural signatures of predictive language processing in Parkinson's disease with and without mild cognitive impairment. Cortex. 141. 112–127. 6 indexed citations

11.

Sampedro, Frederic, Jesús Pérez‐Pérez, Saül Martínez‐Horta, et al.. (2021). Cortical microstructural correlates of plasma neurofilament light chain in Huntington's disease. Parkinsonism & Related Disorders. 85. 91–94. 14 indexed citations

12.

Sierpowska, Joanna, Saül Martínez‐Horta, Jesús Pérez‐Pérez, et al.. (2019). White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease. NeuroImage Clinical. 24. 101965–101965. 30 indexed citations

13.

Escrichs, Anira, Susana Subirà, Matilde Calopa, et al.. (2018). An active cognitive lifestyle as a potential neuroprotective factor in Huntington's disease. Neuropsychologia. 122. 116–124. 15 indexed citations

14.

Sampedro, Frederic, Juan Marín‐Lahoz, Saül Martínez‐Horta, Javier Pagonabarraga, & Jaime Kulisevsky. (2018). Cortical Thinning Associated with Age and CSF Biomarkers in Early Parkinson’s Disease Is Modified by the SNCA rs356181 Polymorphism. Neurodegenerative Diseases. 18(5-6). 233–238. 5 indexed citations

15.

Sampedro, Frederic, Juan Marín‐Lahoz, Saül Martínez‐Horta, Javier Pagonabarraga, & Jaime Kulisevsky. (2018). Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease. Neurobiology of Disease. 124. 29–35. 25 indexed citations

16.

Catalán, María José, Angelo Antonini, Matilde Calopa, et al.. (2017). Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?. eNeurologicalSci. 8. 44–53. 10 indexed citations

17.

Kulisevsky, Jaime, et al.. (2016). Safinamide – A Unique Treatment Targeting Both Dopaminergic and Non-Dopaminergic Systems. European Neurological Review. 11(2). 101–101. 3 indexed citations

18.

Rodríguez‐Revenga, Laia, Javier Pagonabarraga, Beatriz Gómez‐Ansón, et al.. (2010). Motor and mental dysfunction in mother–daughter transmitted FXTAS. Neurology. 75(15). 1370–1376. 20 indexed citations

19.

Emre, Murat, Dag Aarsland, Alberto Albanese, et al.. (2004). Rivastigmine for Dementia Associated with Parkinson's Disease. New England Journal of Medicine. 351(24). 2509–2518. 793 indexed citations breakdown →

20.

Estévez-González, A, Carmen García‐Sánchez, Pilar Otermín, et al.. (2004). Preclinical Memory Profile in Alzheimer Patients with and without Allele APOE-epsilon4. European Neurology. 51(4). 199–205. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact